In the field of cell therapy isolators, Extract Technology is becoming recognised as one of the market leaders. Extract‘s standards for quality and performance ability are at the centre for any project when designing assured containment and aseptic systems.
Based on this growing reputation Extract Technology have recently completed the supply of a multi chamber advance cell therapy isolator for a new state of the art research and manufacturing facility in the Czech Republic.
The client is regarded as a regional leader in the area of cell industrialisation and tissue processing and commissioned Extract Technology for the turn key supply of a bespoke cell therapy isolator.
With advancements in using human cells to treat patients’ illnesses the traditional approach of current medicine may become a thing of the past, with these changes isolator technology faces new challenges including time to market, high level of innovation, flexibility and cost effective solutions. The seven chamber isolator incorporated full process integration of incubators and microscopes within a grade A laminar flow environment, dedicated chambers for process separation, different pressure regime control within each chamber and integrated hydrogen peroxide system for decontamination. Moreover the EU GMP compliant design resulted in increased sterility by reducing potential contamination and cross contamination risks.
The new facility for regenerative medicine and tissue engineering now hosts one of the most advanced cell therapy isolators on the market the utilisation of this isolator technology will minimise human interventions in processing areas which will result in a significant decrease in the risk of microbiological contamination of aseptically manufactured products from the environment.
The successful completion was achieved by the close working relationship between Extract Technology and the client. Technical operations manager, Paul Hudson said “upon completion of the Factory Acceptance testing of this exciting but challenging project there was a great sense of pride throughout Extract Technology in recognition of what we had achieved. From order to delivery in just 10 months is testament to the dedication, hard work ethic, innovative thinking of our project team and confirmation that we had achieved our goal in line with our vision – to be the partner of choice in the world of high containment and Aseptic solutions”.
Contact LBS Biotech Australia
Thank you for your enquiry! LBS Biotech
Australia will be in touch as soon as possible.
Sorry, there seems to have been an error.
Please double check your details and try again.